VR
Verona Pharma
VRNA·NASDAQLondon UKFounded 2005200 employees
Mid CapbiotechPublicRespiratory
Platform: Ensifentrine COPD
Market Cap
$3B
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (VRNA)
Loading VRNA stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| VRN-4215 | VRN-4215 | Preclinical | 1 | PD-1 | Cervical CaPNH | ||
| Motafutibatinib | VRN-9529 | Preclinical | 1 | AuroraA | NSCLC | ||
| Zanuinavolisib | VRN-1844 | Phase 2 | 2 | ALK | Meso |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)